Asunto(s)
Colágeno/genética , Nefritis Hereditaria/genética , Cromosoma X/genética , Adolescente , Adulto , Secuencia de Aminoácidos , Sustitución de Aminoácidos , Niño , ADN/química , ADN/genética , Análisis Mutacional de ADN , Femenino , Ligamiento Genético , Humanos , Masculino , Persona de Mediana Edad , Datos de Secuencia Molecular , Mutación Missense , Nefritis Hereditaria/patología , Mutación Puntual , Polimorfismo Conformacional Retorcido-Simple , Homología de Secuencia de AminoácidoAsunto(s)
Glomérulos Renales/ultraestructura , Nefritis Hereditaria/etiología , Nefritis Hereditaria/patología , Adolescente , Adulto , Membrana Basal/patología , Membrana Basal/ultraestructura , Biopsia , Niño , Humanos , Fallo Renal Crónico/etiología , Glomérulos Renales/patología , Masculino , Microscopía Electrónica , Nefritis Hereditaria/genética , Pronóstico , Proteinuria/etiología , Factores de TiempoRESUMEN
The presence of acetate in the dialysate appears to be superfluous in the new depurative technique indicated as biofiltration, which consists in a standard hemodialysis with high ultrafiltration combined with the reinfusion of 3-4 1/2 liters of solution containing bicarbonate. The presence of acetate could in fact be contraindicated by a number of potential side effects, metabolic, cardiovascular and biological. Hence, starting from the consideration that in standard biofiltration a buffer is already infused directly as bicarbonate, we tried to overcome the potential hazards of the acetate-containing bath simply by using a dialysate without acetate and by increasing the concentration of bicarbonate in the reinfusate. A cumulative clinical experience of 20 months in 4 patients proved the feasibility and safety of the technique and suggests further advantages over standard biofiltration (better control of acid-base equilibrium, better cardiovascular stability.
Asunto(s)
Sangre , Diálisis Renal , Ultrafiltración/métodos , Acetatos/administración & dosificación , Adulto , Bicarbonatos/administración & dosificación , Tampones (Química) , Femenino , Hemodinámica , Humanos , Masculino , Persona de Mediana Edad , Concentración Osmolar , Reología , Sodio , Ultrafiltración/instrumentaciónRESUMEN
Polycentric 384-month study of biofiltration (BF) with AN69s. Since January 1984, 39 uremic dialyzed patients have been included in a randomized prospective study, to evaluate the clinical utility of BF. The trial lasted 9.85 months/pt (384.15 months of total observations) and patients admitted had some not well controlled clinical signs: major acidosis, intradialytic cardiovascular instability, intolerance to acetate dialysis, hypercatabolism, neuropathy, etc. We obtained some positive effects: the incidence of intradialytic hypotension decreased 26.6%; interdialytic body weight gain fell from 3.1 to 2.7 kg (p less than 0.05) and the dialytic time per week was reduced from 12.3 to 10.0 hours (p less than 0.01). At the same time dry body weight increased from 62.4 to 64.6 kg with worthwhile improvement of the acid-base status (ABS) in all patients. This controlled trial showed that BF is particularly useful for patients suffering from severe acidosis and/or cardiovascular instability.
Asunto(s)
Resinas Acrílicas , Acrilonitrilo , Sangre , Membranas Artificiales , Nitrilos , Diálisis Renal , Ultrafiltración/métodos , Acidosis/prevención & control , Acrilonitrilo/análogos & derivados , Adulto , Ensayos Clínicos como Asunto , Femenino , Humanos , Hipotensión/prevención & control , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Distribución Aleatoria , Factores de Tiempo , Ultrafiltración/instrumentaciónRESUMEN
Effects of chronic biofiltration (BF) with PAN membranes on acid-base status (ABS): polycentric study. From the 39 cases in a polycentric study we selected 13 patients with metabolic acidosis (pH 7.23 +/- 0.03), marked reduction of plasma bicarbonate (15.4 +/- 2.2 mEq/l) and hyperkalemia (6.2 +/- 0.6 mEq/l). BF was performed with a continuous post-dilutional supply of HCO3 (85 mmol/h), and attained rapid normalisation of blood bicarbonates and serum potassium during the treatment. After 6 months of BF treatment the pre-dialytic ABS showed remarkable improvement, and values were normal after one year. The remaining 26 patients in the polycentric study, treated by chronic BF without severe acidosis, showed good dialytic tolerance. In 15 of them the supply of bicarbonate was too high (because of moderate post-BF alkalosis) and we had to reduce the buffer inflow to about 50 mmol/h.
Asunto(s)
Equilibrio Ácido-Base , Sangre , Membranas Artificiales , Diálisis Renal , Ultrafiltración/métodos , Acidosis/sangre , Acidosis/prevención & control , Resinas Acrílicas , Acrilonitrilo/análogos & derivados , Adulto , Bicarbonatos/administración & dosificación , Bicarbonatos/sangre , Ensayos Clínicos como Asunto , Femenino , Humanos , Hiperpotasemia/sangre , Hiperpotasemia/prevención & control , Masculino , Persona de Mediana Edad , Ultrafiltración/instrumentaciónRESUMEN
Chronic Renal Failure is a generalized functional impairment, due to Kidneys inability to maintain volume and composition of body fluids and solutes within normal conditions. In the attempt to point out the pathophysiology of Bright's syndrome, the Authors review the "intact nephron hypothesis" and his functional reserve. The uraemic clinical appearance is a very wide field of investigations and beside their own experience, the Authors present some datas and theories to explain the coming out and the evolution of poliuria and oliguria, hypertension, heart pathology, anemia and bleedings, hormonal and metabolic pathways alterations, calcium and bone diseases and central and peripheral uraemic neuropathy.